Treatment of myelodysplastic syndrome with 2 schedules and doses of oral topotecan: A randomized phase 2 trial by the Cancer and Leukemia Group B (CALGB 19803)
David L. Grinblatt, Daohai Yu, Vera Hars, James W. Vardiman, Bayard L. Powell, Sreenivasa Nattam, Lewis R. Silverman, Carlos De Castro, Richard M. Stone, Clara D. Bloomfield, Richard A. Larson
Research output: Contribution to journal › Article › peer-review
5Scopus
citations
Fingerprint
Dive into the research topics of 'Treatment of myelodysplastic syndrome with 2 schedules and doses of oral topotecan: A randomized phase 2 trial by the Cancer and Leukemia Group B (CALGB 19803)'. Together they form a unique fingerprint.